Current evaluation of amenorrhea

Fertility and Sterility

Volumn 86, Issue 5 SUPPL., 2006, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; PROLACTIN;

ARTICLE; ENDOCRINE DISEASE; FEMALE GENITAL TRACT MALFORMATION; FOLLITROPIN BLOOD LEVEL; HUMAN; HYPERPROLACTINEMIA; LABORATORY TEST; MENARCHE; MENSTRUATION DISORDER; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PRIMARY AMENORRHEA; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SECONDARY AMENORRHEA;

AMENORRHEA; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYPERPROLACTINEMIA; HYPOTHALAMIC DISEASES; MENARCHE; OVARIAN FAILURE, PREMATURE; POLYCYSTIC OVARY SYNDROME; PRIMARY OVARIAN INSUFFICIENCY; PROLACTIN; THYROTROPIN;

EID: 33750002551     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.08.013     Document Type: Article

References (53)

1. Stedman's Medical Dictionary. 27th ed. (2000), Lippincott Williams & Wilkins, Philadelphia 56
2. Herman-Giddens M.E., Slora E.J., Wasserman R.C., Bourdony C.J., Bhapkar M.V., Koch G.G., et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics 99 (1997) 505-512
3. Pettersson F., Fries H., and Nillius S.J. Epidemiology of secondary amenorrhea. I. Incidence and prevalence rates. Am J Obstet Gynecol 117 (1973) 80-86
4. Bachmann G., and Kemmann E. Prevalence of oligomenorrhea and amenorrhea in a college population. Am J Obstet Gynecol 144 (1982) 98-102
5. Reindollar R.M., Byrd J.R., and McDonough P.G. Delayed sexual development: a study of 252 patients. Am J Obstet Gynecol 140 (1981) 371-380
6. Reindollar R.H., Novak M., Tho S.P., and McDonough P.G. Adult-onset amenorrhea: a study of 262 patients. Am J Obstet Gynecol 155 (1986) 531-543
7. Mashchak C.A., Kletzky O.A., Davajan V., and Mishell D.R. Clinical and laboratory evaluation of patients with primary amenorrhea. Obstet Gynecol 57 (1981) 715-721
8. Insler V. Gonadotophin therapy: new trends and insights. Int J Fertil 33 (1988) 85-97
9. Doody K.M., and Carr B.R. Amenorrhea. Obstet Gynecol Clin North Am 17 (1990) 361-387
10. Jagiello G. Prevalence of testicular feminization. Lancet 1 (1962) 329
11. Wilson J.D. Syndromes of androgen resistance. Biol Reprod 46 (1992) 168-173
12. Lobo R.A. Primary and secondary amenorrhea. In: Fraser I.S., Jansen R., Lobo R.A., and Whitehead M. (Eds). Estrogens and progestogens in clinical practice (1998), Churchill Livingstone, London
13. Reid R.L. Amenorrhea. In: Copeland L.J. (Ed). Textbook of gynecology. 2nd ed. (1996), WB Saunders, Philadelphia
14. Manuel M., Katayama P.K., and Jones Jr. H.W. The age of occurrence of gonadal tumors in intersex patients with a Y chromosome. Am J Obstet Gynecol 124 (1976) 293-300
15. Turner H.H. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology 23 (1938) 566
16. Turner's syndrome. West J Med 137 (1982) 32-44
17. Toledo S.P., Brunner H.G., Kraaij R., Post M., Dahia P.L., Hayashida C.Y., et al. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J Clin Endocrinol Metab 81 (1996) 3850-3854
18. Aittomaki K., Lucena J.L., Pakarinen P., Sistonen P., Tapanainen J., Gromoll J., et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82 (1995) 959-968
19. Allingham-Hawkins D.J., Babul-Hirji R., Chitayat D., Holden J.J., Yang K.T., Lee C., et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study-preliminary data. Am J Med Genet 83 (1999) 322-325
20. Laml T., Preyer O., Umek W., Hengstschlager M., and Hanzal H. Genetic disorders in premature ovarian failure. Hum Reprod Update 8 (2002) 483-491
21. Morishima A., Grumbach M.M., Simpson E.R., Fisher C., and Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80 (1995) 3689-3698
22. Jones G.S., and De Moraes-Ruehsen M. A new syndrome of amenorrhea in association with hypergonadotropism and apparently normal ovarian follicular apparatus. Am J Obstet Gynecol 104 (1969) 597-600
23. Van Campenhout J., Vauclair R., and Maraghi K. Gonadotropin-resistant ovaries in primary amenorrhea. Obstet Gynecol 40 (1972) 6-12
24. Conway G.S., Kaltsas G., Patel A., Davies M.C., and Jacobs H.S. Characterization of idiopathic premature ovarian failure. Fertil Steril 65 (1996) 337-341
25. Laml T., Preyer J., Umek W., Hengstschlager M., and Hanzal E. Genetic disorders in premature ovarian failure. Hum Reprod Update 8 (2002) 483-491
26. LaBarbera A.R., Miller M.M., Ober C., and Rebar R.W. Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol Microbiol 16 (1988) 115-122
27. Hoek A., Schoemaker J., and Drexhage H.A. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 18 (1997) 107-134
28. Nelson L.M., Anasti J.N., and Flack M.R. Premature ovarian failure. In: Adashi E.Y., Rock J.A., and Rosenwaks Z. (Eds). Reproductive endocrinology, surgery, and technology (1996), Lippincott-Raven, Philadelphia 1393-1410
29. Rebar R.W., and Connolly H.V. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 53 (1990) 804-810
30. Touraine P., Plu-Bureau G., Beji C., Mauvais-Jarvis P., and Kuttenn F. Long-term follow-up of 246 hyperprolactinemic patients. Acta Obstet Gynecol Scand 80 (2001) 162-168
31. Brenner S.H., Lessing J.B., Quagliarello J., and Weiss G. Hyperprolactinemia and associated pituitary prolactinomas. Obstet Gynecol 65 (1985) 661-664
32. Schlechte J., Dolan K., Sherman B., Chapler F., and Luciano A. The natural history of untreated hyperprolactinemia: a prospective analysis. J Clin Endocrinol Metab 68 (1989) 412-418
33. Marshall J.C., Eagleson C.A., and McCartney C.R. Hypothalamic dysfunction. Mol Cell Endocinol 183 (2002) 29-32
34. Imani B., Eijkemans M.J., te Velde E.R., Habbema J.D., and Fauser B.C. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril 77 (2002) 91-97
35. Rarick L.D., Shangold M.M., and Ahmed S.W. Cervical mucus and serum estradiol as predictors of response to progestin challenge. Fertil Steril 54 (1990) 353-355
36. Nakamura S., Douchi T., Oki T., Ijuin H., Yamamoto S., and Nagata Y. Relationship between sonographic endometrial thickness and progestin-induced withdrawal bleeding. Obstet Gynecol 87 (1996) 722-725
37. Frisch R.E., and McArthur J.W. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 185 (1974) 949-951
38. Lucas A.R., Crowson C.S., O'Fallon W.M., and Melton III L.J. The ups and downs of anorexia nervosa. Int J Eat Disord 26 (1999) 397-405
39. Warren M.P., and Goodman L.R. Exercise-induced endocrine pathologies. J Endocrinol Invest 26 (2003) 873-878
40. Rosenfield R.L. Clinical review 6: diagnosis and management of delayed puberty. J Clin Endocrinol Metab 70 (1990) 559-562
41. Hall J.E. Physiologic and genetic insights into the pathophysiology and management of hypogonadotropic hypogonadism. Ann Endocrinol 60 (1999) 93-101
42. Layman L.C., McDonough P.G., Cohen D.P., Maddox M., Tho S.P., and Reindollar R.H. Familial gonadotropin-releasing hormone resistance and hypogonadotropic hypogonadism in a family with multiple affected individuals. Fertil Steril 75 (2001) 1148-1155
43. Sheehan H.L. Simmond's disease due to post-partum necrosis of the anterior pituitary. Q J Med 8 (1939) 277
44. Davies M.C., Hall M.L., and Jacobs H.S. Bone mineral loss in young women with amenorrhoea. BMJ 301 (1990) 790-793
45. Martin K.A., Hall J.E., Adams J.M., and Crowley Jr. W.F. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab 77 (1993) 125-129
46. Moran C., Azziz R., Carmina E., Dewailly D., Fruzzetti F., Ibanez L., et al. 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol 183 (2000) 1468-1474
47. Legro R.S. Polycystic ovary syndrome: the new millennium. Mol Cell Endocrinol 184 (2001) 87-93
48. Bili H., Laven J., Imani B., Eijkemans M.J., and Fauser B.C. Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years. Eur J Endocrinol 145 (2001) 749-755
49. Zawadzki J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A., Givens J.R., Haseltine F.P., and Merriam G.M. (Eds). Polycystic ovary syndrome (1992), Blackwell, Boston 377-384
50. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
51. Dunaif A., and Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med 52 (2001) 401-419
52. Legro R.S., Kunselman A.R., Dodson W.C., and Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84 (1999) 165-169
53. Dunaif A., and Finegood D.T. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 81 (1996) 942-947